Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Delta Djakarta Tbk. (DLTA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Delta Djakarta Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Delta Djakarta Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Delta Djakarta Tbk. trades at Rp1,755 (market cap 1.42T, 137.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Delta Djakarta Tbk. is far larger — about 2.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 137.1K). Which is the better fit depends on your goals.

DLTALABS
Market Cap
1.42T584.6B
Volume
137.1K817.3K
Lot
1.37K8.17K
Turnover
240.59M120.01M
Average Price
1,754.85146.84
Value
240.59M120.01M
Indicative Equilibrium Price
1,755146
Indicative Equilibrium Volume
459

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DLTA
View details
LABS
View details

About Delta Djakarta Tbk.

The Company was originally established by a German business group in 1932. It produced the very first beer, Anker Bir, in the country. This makes the Anker Brand the first and original Indonesian beer. The company has been changing hands from German to Dutch, and to Japanese, until it was finally established as PT Delta Djakarta in 1970. It has become and remained as a strong player in the industry. Today, PT Delta Djakarta produces Anker Bir, Anker Stout and Shanta Shandy as well as licensed brands San Miguel and Carlsberg. Distribution extends from Medan to Irian Jaya and from Jakarta to Manado. Collectively, these brands own a major share in the beer industry. PT Delta Djakarta was listed as a public company in the Jakarta and Surabaya Stock Exchanges in 1983. Today, shareholders include the city Government of DKI Jakarta and San Miguel Brewing International Limited.

Read more on DLTA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS